Our Businesses

Business Investment

Investing to enhance the competitiveness of our tobacco business which is the primary focus in our resource allocation. Current investments in our pharmaceutical, beverage and processed food businesses are intended for building fundamentals to strengthen future profit contribution.

Tobacco Business

The JT Group does business in more than 120 countries around the world and has grown to become the world's third largest tobacco manufacturer by market share. We will continue to vigorously pursue further growth by leveraging our product brands – our greatest assets.

* Please be reminded that this section of our website is intended to explain the business operations of the JT Group to investors, and not to promote sales of tobacco products to encourage smoking by consumers.

Overview

As the core business and profit growth engine of the JT Group, we are strengthening our business by promoting globalization, enhancing the presence of our product brands and taking on innovation challenges beyond conventional thinking. We also leverage the strength of our diverse human resources.

International Tobacco

JT International (JTI) represents the international activities of the JT Group's tobacco business. JTI manufactures and sells more than 90 brands of tobacco products in more than 120 countries. It is the profit growth engine of the Group driven by its diversified geographic profile and the strength of its brands and people.

Japanese Domestic Tobacco

Japan is one of the largest tobacco markets in the world. We own 9 of the 10 top-selling products in Japan. We are the undisputed market leader with over 60% of market share in the year ended March 2014.

Anti-illicit Trade

Illicit trade is a major concern not only for the tobacco industry, but for wider society. The JT Group takes a zero tolerance approach towards all these criminal activities with an emphasis on eliminating counterfeit products.

Other Businesses

In addition to tobacco, JT has business interests in the pharmaceutical, beverage and processed food sectors. We are investing in these businesses to strengthen their future profit contribution.

Pharmaceutical

To save people around the world from diverse diseases, JT engages in research and development aimed at creating unique, world-class, innovative drugs.

Beverage

Our aim is to offer safe and delicious beverages that consumers would choose to share with their loved ones.

Processed Food

Our processed food business offers safe and delicious food to our consumers those that they care about most.